首页> 外文期刊>The Internet Journal of Dermatology >Large CD30- Positive Cells In Cutaneous Benign Lymphoid Infiltrate
【24h】

Large CD30- Positive Cells In Cutaneous Benign Lymphoid Infiltrate

机译:皮肤良性淋巴样浸润中的大CD30-阳性细胞

获取原文
       

摘要

We are reporting a clinical presentation for a case that resamples CD30 positive lymphoproliferative disorder. The clinical challenge, the deferential diagnosis and review of literature have been discussed. Clinical Course This is the case of a 44 year old single smoker male with past medical history of duodenal ulcer, benign prostatic hyperplasia, diabetes mellitus, hyperlipidemia and hypertension. The patient presented to the hospital for evaluation of a 6 year history of multiple non pruritic red nodulo-plaque lesions on the head and neck regions without lymphodenpathy or any other systemic symptoms or signs (figure 1). One year before presentation patient had undergone “isotretinoin” therapy for 6 months for a clinical diagnosis of “ Granulomatous Rosacea” without any benefit. Laboratory work up revealed normal cell blood count, normal electrolytes, normal urine analysis, negative anti-nuclear antibody (ANA), HBsAg and HCV none reactive. The patient was started on the following medications; glyburide, metformine, doxazosin and amlodipine about two years after the onset of the above complaint. The first clinical impression was set for Jessner lymphocytic infiltrate with differential diagnosis of lupus erythematosus and cutaneous sarcoidosis.The first skin lesion biopsy from the temporal area revealed normal epidermal histological features with dense perivascular and periadnexal lymphocytic infiltrate in the dermis. No epitheloid granuloma identified, and the findings most likely suggestive of Jessner lymphocytic infiltrate, and less likely to be lupus erythematosus.Hence, the patient was treated with antimalarial drugs (hydroxychloroquine) 200 mg/day for 5 months but without improvement. A second biopsy was performed later on from neck area and showed unremarkable epidermis with dense dermal perivascular and periadnexal lymphocytic infiltration that has a nodular appearance with occasional diffuse expansion within the dermis, it is composed mainly of small to medium sized lymphocytes admixed with histiocytes, smaller number of large lymphocytes, many eosinophils and rare plasma cells, the small lymphoid cells frequently show cleaved or irregular nuclear membrane. Mitotic figures are occasionally seen, and prominent vascular channels in many areas with plump endothelial cells identified (Figure 3 A, B).Immunohistochemistry staining was performed and the large cells expressed CD3, CD30 and CD45 (Figure 3. C, D). And were negative for CD20, Alk, EBV (figure 3.E, F) and EMA. The proliferative index by Ki-67 labeling is 20%. Therefore, the findings were in keeping with the diagnosis of CD30 positive T – cell lymphoproliferative disorder. The patient was treated with prednisolone (40 mg/ day) for one week, reduced gradually to (5 mg/day). Methotrexate (25 mg /week) for 6 months and after treatment, lesions mildly have improved and decreased in size but fully recovery had not been accomplished and they relapsed in two months after ceasing methotrexate (figure 2).Further molecular testing for T cell rearrangement was performed on paraffin embedded tissue and no monoclonality was detected.
机译:我们正在报告对CD30阳性淋巴组织增生性疾病重新取样的病例的临床表现。讨论了临床挑战,鉴别诊断和文献复习。临床过程这是一名44岁的单吸烟男性,过去有十二指肠溃疡,良性前列腺增生,糖尿病,高脂血症和高血压的病史。该患者前往医院评估了头颈部颈部多个非瘙痒性红色结节性病变的6年病史,无淋巴结肿大或任何其他全身性症状或体征(图1)。在就诊前一年,患者接受了“异维A酸”治疗6个月,以临床诊断为“肉芽肿性酒渣鼻”,没有任何益处。实验室检查显示细胞血细胞计数正常,电解质正常,尿液分析正常,抗核抗体(ANA)阴性,HBsAg和HCV无反应。患者开始接受以下药物治疗;在上述症状发作约两年后,格列本脲,二甲双胍,多沙唑嗪和氨氯地平开始治疗。对Jessner淋巴细胞浸润的首次临床印象是可鉴别诊断红斑狼疮和皮肤结节病。未发现上皮性肉芽肿,该发现最有可能提示Jessner淋巴细胞浸润,而不太可能是红斑狼疮。因此,该患者接受200 mg /天的抗疟药(羟氯喹)治疗5个月,但无改善。稍后从颈部进行第二次活检,显示表皮无明显变化,真皮周围血管密集,而肾周周围淋巴细胞浸润,呈结节状外观,偶尔在真皮内扩散扩散,主要由中小尺寸淋巴细胞与组织细胞混合而成,较小大量大淋巴细胞,许多嗜酸性粒细胞和稀有浆细胞,小的淋巴样细胞常显示出分裂或不规则的核膜。偶尔见到有丝分裂图,并在许多区域发现了明显的血管通道,内皮细胞丰满(图3 A,B)。进行了免疫组织化学染色,大细胞表达了CD3,CD30和CD45(图3.C,D)。 CD20,Alk,EBV(图3.E,F)和EMA均为阴性。 Ki-67标记的增殖指数为20%。因此,研究结果与CD30阳性T细胞淋巴增生性疾病的诊断相符。该患者接受泼尼松龙(40 mg /天)治疗一周,逐渐减少至(5 mg /天)。甲氨蝶呤(25 mg /周)治疗6个月后,病灶轻度改善并缩小,但尚未完全恢复,在停用甲氨蝶呤后的两个月内复发(图2)。进一步的分子检测T细胞重排对石蜡包埋的组织进行了检测,未检测到单克隆性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号